Zobrazeno 1 - 5
of 5
pro vyhledávání: '"K V Meyer"'
Autor:
Carolina Iturriaga, Nat Eiffler, Rad Aniba, Rym Ben-Othman, Guillermo Perez-Mateluna, Jessica K. V. Meyer, Eleanor N. Fish, Tobias R. Kollmann, Nicolas Severino, Stephen Stick, Arturo Borzutzky, Cecilia Perret, José A. Castro-Rodriguez, Diego Garcia-Huidobro
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background SARS-CoV-2 infection rapidly spreads in populations due to the high rates of community transmission. Interrupting the shedding of SARS-CoV-2 may reduce the incidence of Coronavirus Disease 19 (COVID-19). Herein we provide a protoc
Externí odkaz:
https://doaj.org/article/60f714c94caf4155b56bf4aac058f1d8
Autor:
Jessica K V Meyer, Amaia Bernard Ortiz de Rozas, Ivan Muñoz, Catalina Burmeister, Carlo Macchiavello, Lauren Lendzion, Diego García-Huidobro
Publikováno v:
Health Promotion International. 38
SummaryIn Chile, the prevalence of tobacco, alcohol and drug use among adolescents is very high. Decades of research indicate that parenting interventions reduce these risky behaviors. However, there are no parenting interventions validated in Chile
Autor:
Diego Garcia-Huidobro, Catalina Burmeister, Gabriela Diaspro, Jessica K. V. Meyer, Ivan Muñoz
Introduction: Substance use is a significant global concern. Strengthening parenting in families with adolescents has been shown to reduce substance use initiation. The ¡Vamos por Más! (¡VxM!) program is a positive-parenting program developed in C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e08b01b30b5b09fec4885d89ec7770f
https://doi.org/10.21203/rs.3.rs-789599/v1
https://doi.org/10.21203/rs.3.rs-789599/v1
Autor:
Elizabeth Loomis, Kevin Fiscella, Mechelle Sanders, Holly Ann Russell, Jessica K. V. Meyer, Teraisa Mullaney
Publikováno v:
Journal of the American Board of Family Medicine : JABFM. 34(6)
Background: Substance use disorders, including opioid use disorder (OUD), are understood as chronic diseases with a relapsing and remitting course and no known cure. Medications for OUD (MOUD) are well established with decades of evidence supporting
Publikováno v:
Endocrinology. 136:1759-1765
11 beta-hydroxysteroid dehydrogenase (11 beta-OHSD) protects the non-selective renal mineralocorticoid receptor from the endogeneous glucocorticoid cortisol. Thus, drugs inhibiting 11 beta-OHSD might enhance urinary loss of potassium. In an attempt t